Abdominal Pain News and Research

RSS
Abdominal pain is traditionally described by its chronicity (acute or chronic), its progression over time, its nature (sharp, dull, colicky), its distribution (by various methods, such as abdominal quadrant (left upper quadrant, left lower quadrant, right upper quadrant, right lower quadrant) or other methods that divide the abdomen into nine sections), and by characterization of the factors that make it worse, or alleviate it.
IBS patients are at no greater risk of having polyps, colon cancer than healthy people undergoing colonoscopies

IBS patients are at no greater risk of having polyps, colon cancer than healthy people undergoing colonoscopies

Abused children more likely to suffer abdominal pain and nausea

Abused children more likely to suffer abdominal pain and nausea

Electromagnetic pulses decrease pain and inflammation associated with osteoarthritis of knee

Electromagnetic pulses decrease pain and inflammation associated with osteoarthritis of knee

Salmonella Montevideo outbreak: FDA investigates Daniele International's pepper supply chain

Salmonella Montevideo outbreak: FDA investigates Daniele International's pepper supply chain

Salmonella Tennessee in Basic Food Flavors' HVP: FDA taking steps to protect consumers

Salmonella Tennessee in Basic Food Flavors' HVP: FDA taking steps to protect consumers

Possible Salmonella contamination: Mincing Overseas Spice recalls two lots of black pepper

Possible Salmonella contamination: Mincing Overseas Spice recalls two lots of black pepper

FDA takes steps to protect consumers from potential Salmonella infection

FDA takes steps to protect consumers from potential Salmonella infection

Worm proteins may provide option in management of gastrointestinal inflammation in IBD patients

Worm proteins may provide option in management of gastrointestinal inflammation in IBD patients

KAPIDEX to be marketed as DEXILANT in the U.S.

KAPIDEX to be marketed as DEXILANT in the U.S.

Data evaluating safety, efficacy of STELARA and REMICADE in patients with plaque psoriasis to be presented

Data evaluating safety, efficacy of STELARA and REMICADE in patients with plaque psoriasis to be presented

Merck’s MF/F Phase III study data presented at AAAAI annual meeting

Merck’s MF/F Phase III study data presented at AAAAI annual meeting

Harvard Professor urges medical community to use ultrasound for diagnosing acute female pelvic conditions

Harvard Professor urges medical community to use ultrasound for diagnosing acute female pelvic conditions

Baxter Healthcare's IIPV product recall of HomeChoice peritoneal dialysis cyclers classified as Class I recall

Baxter Healthcare's IIPV product recall of HomeChoice peritoneal dialysis cyclers classified as Class I recall

Cause of abdominal pain in children with no apparent reason: Psychosomatic component

Cause of abdominal pain in children with no apparent reason: Psychosomatic component

Colonoscopy screening recommended for people with family history of colon cancer

Colonoscopy screening recommended for people with family history of colon cancer

FDA works closely with different states to investigate the outbreak of Salmonella Montevideo infections

FDA works closely with different states to investigate the outbreak of Salmonella Montevideo infections

Gaucher disease: FDA approves VPRIV

Gaucher disease: FDA approves VPRIV

NIH panel proposes multiple management strategies for lactose intolerant individuals

NIH panel proposes multiple management strategies for lactose intolerant individuals

Soy products meet nutritional needs of people with lactose intolerance

Soy products meet nutritional needs of people with lactose intolerance

FDA Gastrointestinal Drugs Advisory Committee supports approval of XIFAXAN 550 mg for management of HE

FDA Gastrointestinal Drugs Advisory Committee supports approval of XIFAXAN 550 mg for management of HE

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.